Case Report: Significant Response to Immune Checkpoint Inhibitor Camrelizumab in a Heavily Pretreated Advanced ER+/HER2− Breast Cancer Patient With High Tumor Mutational Burden

by Rong Wang, Rong Wang, Yuchen Yang, Wei-Wu Ye, Wei-Wu Ye, Jianxing Xiang, Songan Chen, Wei-Bin Zou, Wei-Bin Zou, Xiao-Jia Wang, Xiao-Jia Wang, Tianhui Chen, Tianhui Chen, Wen-Ming Cao, Wen-Ming Cao
Published 2021-02-01

Non-Invasive Biomarkers for Early Detection of Breast Cancer

by Jiawei Li, Xin Guan, Zhimin Fan, Lai-Ming Ching, Yan Li, Xiaojia Wang, Wen-Ming Cao, Dong-Xu Liu
Published 2020-09-01

Comprehensive mutation detection of BRCA1/2 genes reveals large genomic rearrangements contribute to hereditary breast and ovarian cancer in Chinese women

by Wen-Ming Cao, Ya-Bing Zheng, Yun Gao, Xiao-Wen Ding, Yan Sun, Yuan Huang, Cai-Jin Lou, Zhi-Wen Pan, Guang Peng, Xiao-Jia Wang
Published 2019-06-01

Deleterious Mutations in DNA Repair Gene FANCC Exist in BRCA1/2-Negative Chinese Familial Breast and/or Ovarian Cancer Patients

by Zhi-Wen Pan, Xiao-Jia Wang, Tianhui Chen, Xiao-Wen Ding, Xiyi Jiang, Yun Gao, Wen-Ju Mo, Yuan Huang, Cai-Jin Lou, Wen-Ming Cao
Published 2019-03-01

Profiling Receptor Tyrosine Kinase Fusions in Chinese Breast Cancers

by Zhonghua Tao, Zhonghua Tao, Jianxia Liu, Ting Li, Ting Li, Hong Xu, Kai Chen, Jian Zhang, Jian Zhang, Hao Zhou, Jie Sun, Jinming Han, Zhaoji Guo, Hua Yang, Wen-Ming Cao, Xichun Hu, Xichun Hu
Published 2021-09-01